Your browser doesn't support javascript.
loading
Two-year regional grey and white matter volume changes with natalizumab and fingolimod.
Preziosa, Paolo; Rocca, Maria A; Pagani, Elisabetta; Storelli, Loredana; Rodegher, Mariaemma; Moiola, Lucia; Filippi, Massimo.
  • Preziosa P; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Rocca MA; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Pagani E; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Storelli L; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Rodegher M; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Moiola L; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Filippi M; Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
J Neurol Neurosurg Psychiatry ; 91(5): 493-502, 2020 05.
Article en En | MEDLINE | ID: mdl-32111638

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Sustancia Gris / Sustancia Blanca / Clorhidrato de Fingolimod / Natalizumab / Factores Inmunológicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Sustancia Gris / Sustancia Blanca / Clorhidrato de Fingolimod / Natalizumab / Factores Inmunológicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article